Genufood Energy Enzymes Corp.
Genufood Energy Enzymes Corp.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Due To Related Parties Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Related Party | 0 | 0 | - | - | - | 0 | - | - | - | - | - | - | - | |||||
Assets | ||||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | ||||||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Due From Related Parties Current | - | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Prepaid Expense Current | 0 | 0 | - | - | - | 0 | - | - | - | - | - | - | - | |||||
Investments | - | - | - | - | - | - | - | - | - | 0 | 1 | 1 | 1 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | |||||
Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |||||
Liabilities And Stockhold… | ||||||||||||||||||
Notes Payable Current | - | - | 0 | 0 | 0 | 0 | - | - | - | 0 | - | 0 | 0 | |||||
Accounts Payable Current | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | ||||||||||||||||||
Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accrued Liabilities Current | 0 | 0 | 0 | 0 | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Commitments And Contingencies | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | |||||
Common Stock Value | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 16 | 16 | |||||
Stockholders Equity | ||||||||||||||||||
Stockholders Equity | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |||||
Common Stock Discount On Shares | - | - | - | - | - | - | - | - | - | - | -7 | -7 | -7 | |||||
Retained Earnings Accumulated Deficit | -11 | -11 | -10 | -10 | -10 | -10 | -10 | -10 | -10 | -10 | -8 | -8 | -8 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | - | - | - | - | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | |||||
Common Stock Shares Issued | 809 | 809 | 809 | 809 | 300 | 300 | 300 | 300 | 300 | 300 | 284 | 217 | 211 | |||||
Shares Outstanding | 809 | 809 | 809 | 809 | 300 | 300 | 300 | 300 | 300 | 300 | 284 | 217 | 211 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -3.37% | -3.37% | -76.40% | - | - | - | - | - | - | - | - | - |
| 2023 | -14.68% | -14.68% | -13.14% | 14.00% | 4.72% | 1.11% | -0.33% | -93.94% | -0.88% | 11.25% | 11.25% | 7.50% |
| 2022 | 0.00% | -36.00% | -40.00% | 131.46% | 20.20% | 107.35% | -11.29% | 12.90% | -3.23% | -15.68% | -28.06% | -28.06% |
| 2021 | - | - | - | 18.29% | 15.37% | -4.99% | -33.33% | -33.33% | -46.67% | -53.64% | 40.91% | -27.27% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | ||||||||||||||||||
| Current Ratio | 0.24 | 1.16 | 2.40 | 3.06 | 0.21 | 0.74 | 1.27 | 1.76 | 2.36 | 0.33 | 0.17 | 0.29 | 0.53 | |||||
| Quick Ratio | 0.17 | 1.09 | 2.28 | 2.97 | 0.18 | 0.67 | 1.15 | 1.62 | 2.22 | 0.09 | 0.17 | 0.26 | 0.53 | |||||
| Working Capital | -88.71K | 18.50K | 144.24K | 215.74K | -199.50K | -54.12K | 48.79K | 113.89K | 176.35K | -70.30K | -141.82K | -160.83K | -169.96K | |||||
Leverage & Debt | ||||||||||||||||||
| Debt to Equity | -4.55 | 2.15 | 0.74 | 0.51 | -1.18 | -2.46 | 9.06 | 1.74 | 0.87 | 0.42 | 0.14 | 0.36 | 0.57 | |||||
| Interest Coverage TTM | -8,237.33 | -216,148.00 | -148,937.33 | -142,751.33 | -78,900.00 | -58,140.83 | -66,327.40 | -8,306.52 | -693.21 | -209.71 | -125.89 | -110.84 | -164.03 | |||||
| Debt Ratio | 0.94 | 0.57 | 0.38 | 0.31 | 3.71 | 1.36 | 0.79 | 0.57 | 0.42 | 0.27 | 0.12 | 0.26 | 0.36 | |||||
Efficiency & Turnover | ||||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | ||||||||||||||||||
| Diluted EPS TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | - | |||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | ||||||||||||||||||
| Net Revenue Growth (1Y) | - | - | - | - | - | - | - | - | - | - | - | -100.00% | -100.00% | |||||
| Net Income Growth (1Y) | 44.57% | 77.99% | -54.05% | -54.34% | -71.35% | -74.15% | 409.23% | 325.62% | 257.50% | 255.12% | -119.15% | -128.00% | -171.43% | |||||
| EPS Growth (1Y) | -46.44% | 1.40% | -82.98% | -71.13% | -71.35% | -81.43% | 291.88% | 208.87% | 151.80% | 71.71% | -107.58% | -111.75% | -130.88% | |||||
Valuation Metrics | ||||||||||||||||||
| P/E TTM | -8.43 | -0.92 | -25.83 | -18.99 | -24.07 | -29.74 | -3.89 | -3.51 | -6.03 | -4.58 | -33.84 | -50.79 | -21.38 | |||||
| P/B TTM | -190.03 | 10.77 | 118.96 | 57.75 | -44.71 | -125.84 | 267.78 | 55.65 | 56.17 | 24.63 | 7.39 | 25.52 | 13.20 | |||||
| Market Cap | 4.85M | 578.65K | 16.60M | 11.85M | 9.59M | 10.49M | 5.44M | 4.79M | 8.39M | 6.24M | 9.29M | 16.31M | 8.32M | |||||
| Enterprise Value | 4.83M | 452.73K | 16.46M | 11.64M | 9.66M | 10.45M | 5.23M | 4.55M | 8.10M | 6.33M | 9.27M | 16.28M | 8.16M | |||||
Calculated Values | ||||||||||||||||||
| Free Cash Flow TTM | -360.22K | -372.48K | -337.64K | -293.79K | -241.16K | -222.83K | -266.27K | -288.55K | -318.53K | -304.59K | -246.86K | -238.09K | -223.10K | |||||
| Net Debt | -19.62K | -125.92K | -134.81K | -211.02K | 71.95K | -34.22K | -211.15K | -242.97K | -287.73K | 91.48K | -28.24K | -29.49K | -159.24K | |||||
Per-Share and Margin | ||||||||||||||||||
| EPS TTM | ||||||||||||||||||
| Adjusted EPS TTM | ||||||||||||||||||
| Cash Flow Per Share TTM | ||||||||||||||||||
| Pretax Margin TTM | ||||||||||||||||||
| Stock Comp to Revenue TTM | ||||||||||||||||||
Turnover Ratios and Averages | ||||||||||||||||||
| Average Assets | ||||||||||||||||||
| Average Equity | ||||||||||||||||||
| Average Inventory | ||||||||||||||||||
| Average Receivables | ||||||||||||||||||
| Average Accounts Payables | ||||||||||||||||||
| Inventory Turnover TTM | ||||||||||||||||||
| Payables Turnover TTM | ||||||||||||||||||
| Days Inventory Outstanding TTM | ||||||||||||||||||
| Days Payables Outstanding TTM | ||||||||||||||||||
| Cash Conversion Cycle TTM | ||||||||||||||||||
| Working Capital to Revenue | ||||||||||||||||||
| Deferred Revenue to Revenue | ||||||||||||||||||
Growth Rates | ||||||||||||||||||
| Total Assets Growth (1Y) | ||||||||||||||||||
| Total Assets Growth (3Y) | ||||||||||||||||||
| Total Assets Growth (5Y) | ||||||||||||||||||
| Dividends Paid Growth (1Y) | ||||||||||||||||||
| Dividends Paid Growth (3Y) | ||||||||||||||||||
| Dividends Paid Growth (5Y) | ||||||||||||||||||
| EPS Growth (3Y) | ||||||||||||||||||
| EPS Growth (5Y) | ||||||||||||||||||
| Net Income Growth (3Y) | ||||||||||||||||||
| Net Income Growth (5Y) | ||||||||||||||||||
| Net Profit Margin Growth (1Y) | ||||||||||||||||||
| Net Profit Margin Growth (3Y) | ||||||||||||||||||
| Net Profit Margin Growth (5Y) | ||||||||||||||||||
| Net Revenue Growth (3Y) | ||||||||||||||||||
| Net Revenue Growth (5Y) | ||||||||||||||||||
| Deferred Revenue Growth (1Y) | ||||||||||||||||||
| Retained Earnings Growth (1Y) | ||||||||||||||||||
Credit, Liquidity, Returns, Payout | ||||||||||||||||||
| Cash Ratio | ||||||||||||||||||
| Net Working Capital | ||||||||||||||||||
| Debt to EBITDA TTM | ||||||||||||||||||
| Net Debt to EBITDA TTM | ||||||||||||||||||
| Net Debt to Equity | ||||||||||||||||||
| Altman A | ||||||||||||||||||
| Altman B | ||||||||||||||||||
| Altman C | ||||||||||||||||||
| Altman D | ||||||||||||||||||
| Altman E | ||||||||||||||||||
| Altman Z-Score | ||||||||||||||||||
| ROA TTM | ||||||||||||||||||
| ROE TTM | ||||||||||||||||||
| NOPAT TTM | ||||||||||||||||||
| ROIC TTM | ||||||||||||||||||
| Effective Tax Rate TTM | ||||||||||||||||||
| Payout Ratio TTM | ||||||||||||||||||
| Dilution Ratio | ||||||||||||||||||
| Retained Earnings to Equity | ||||||||||||||||||
| Treasury Stock to Equity | ||||||||||||||||||
| Treasury Stock Change (1Y) | ||||||||||||||||||
| Accrued to Current Liabilities | ||||||||||||||||||
| NCAV | ||||||||||||||||||
| NCAV Per Share TTM | ||||||||||||||||||
Valuation Ratios | ||||||||||||||||||
| P/CF TTM | ||||||||||||||||||
| Dividend Yield TTM | ||||||||||||||||||
| Free Cash Flow Yield TTM | ||||||||||||||||||
| EV EBITDA TTM | ||||||||||||||||||
| EV EBIT TTM | ||||||||||||||||||
| Stock Compensation TTM | ||||||||||||||||||
| Adjusted Net Income TTM | ||||||||||||||||||
| Billings TTM | ||||||||||||||||||
| Total Debt | ||||||||||||||||||
| Invested Capital | ||||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Genufood Energy Enzymes Corp. (GFOO) — SEC Financial Statements & Analysis
Genufood Energy Enzymes Corp. (GFOO) is a medicinal chemicals & botanical products company, incorporated in NV. Genufood Energy Enzymes Corp. trades on OTC as: GFOO. Based on its latest SEC filing (Form 10-Q, period ending 2023-12-31), Genufood Energy Enzymes Corp. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of -4.55x, a Price-to-Book (P/B) ratio of -190.03x (TTM), at a market cap of $4.85M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Debt To Equity
- -4.55x
- P/B TTM
- -190.03x
- Market Cap
- $4.85M
Data as of 2023-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Genufood Energy Enzymes Corp. in?
Genufood Energy Enzymes Corp. (GFOO) operates in the Medicinal Chemicals & Botanical Products industry.
What is GFOO's market cap?
Genufood Energy Enzymes Corp. (GFOO) has a market capitalization of $4.85M as of 2023-12-31.
What exchange does GFOO trade on?
Genufood Energy Enzymes Corp. (GFOO) trades on the OTC.
Where is Genufood Energy Enzymes Corp. incorporated?
Genufood Energy Enzymes Corp. is incorporated in NV.